Ducentis Biotheapeutics

Preclinical stage company developing therapeutics for inflammatory and auto-immune diseases

placeWitney, England, United Kingdom calendar_todayFounded 2015 groups6 employees language ducentisbio.com

Registered entities

Investor mix

2 investors on record; lead investors include LifeArc.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon